Ischemic Stroke Clinical Trials in Minneapolis, Minnesota

6 studies are recruiting for ischemic stroke in Minneapolis, Minnesota right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY

   The overall goal of the DISCOVERY study is to better understand what factors contribute to changes in cognitive (i.e., thinking and memory) abilities in patients who experienced a stroke. The purpose of the study is to help doctors identify patients at risk for dementia (decline in memory, thinking…

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Minnesota Health, Minneapolis, Minnesota

   Locations

   31 in total

   Run by

   Massachusetts General Hospital

   See if you can join NCT04916210 on ClinicalTrials.gov

2. Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

   This is a Phase 2/3 study evaluating the safety and efficacy of DM199 (rinvecalinase alfa) in treating participants with moderate stroke severity, who present within 24 hours of Acute Ischemic Stroke (AIS) onset due to small and medium vessel occlusions. This study focuses on participants with limi…

   Stage

   Phase 2

   Ages

   18 to 90

   Site

   Abbott Northwestern Hospital, Minneapolis, Minnesota

   Locations

   86 in total

   Run by

   DiaMedica Therapeutics Inc

   See if you can join NCT05065216 on ClinicalTrials.gov

3. Strategy for Improving Stroke Treatment Response

   SISTER is a Phase-II, prospective, randomized, placebo-controlled, blinded, dose finding trial that aims to determine the safety and preliminary efficacy of TS23, a monoclonal antibody against the alpha-2 antiplasmin (a2-AP), in acute ischemic stroke.

   Stage

   Phase 2

   Ages

   18 and older

   Site

   M Health Fairview University of Minnesota Medical Center, Minneapolis, Minnesota

   Locations

   52 in total

   Run by

   Translational Sciences, Inc.

   See if you can join NCT05948566 on ClinicalTrials.gov

4. Continuous Dual Aspiration Technique With Zoom System for Stroke

   This study is designed to evaluate the effectiveness, safety and clinical performance of ADAPT 2.0, first-line aspiration neurothrombectomy with Zoom System with Continuous Dual Aspiration Technique (CDAT).

   Stage

   Not phased

   Ages

   18 and older

   Site

   Allina Health, Minneapolis, Minnesota

   Locations

   17 in total

   Run by

   Imperative Care, Inc.

   See if you can join NCT07491952 on ClinicalTrials.gov

5. Feasibility of a Remotely Delivered Step Count Intervention in Chronic Stroke

   The goal of this study is to explore the feasibility of a new approach to rehabilitation that focuses on step count. Participants will complete 6 telephone or Zoom-based sessions with an occupational therapist over 6 weeks and use a step count tracker during that time. They will also complete quest…

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Minnesota, Minneapolis, Minnesota

   Run by

   University of Minnesota

   See if you can join NCT07649135 on ClinicalTrials.gov

6. StrokeNet Thrombectomy Endovascular Platform

   STEP is a Randomized, Multifactorial, Adaptive Platform trial that seeks to optimize the care of patients with acute ischemic stroke (AIS) due to large (LVO) or medium vessel occlusions (MVO).

   Stage

   Not phased

   Ages

   18 and older

   Site

   M Health Fairview University of Minnesota Medical Center, Minneapolis, Minnesota

   Locations

   41 in total

   Run by

   Medical University of South Carolina

   See if you can join NCT06289985 on ClinicalTrials.gov